Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 09, 2025 08:30 ET | Source: Pluri Inc.

Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment

Weinstein brings a global track record of transforming companies through value unlocking, and participation in over 20 M&A transactions and more than $5 billion in exits across healthcare,...
December 09, 2025 08:00 ET | Source: Teva Pharmaceutical Industries Ltd

Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a broad patient population1Olanzapine LAI is designed to...
December 09, 2025 06:00 ET | Source: Tower Semiconductor

Tower Semiconductor to Attend the Nomura’s CES Technology Conference

Tower Semiconductor will participate in the Nomura’s CES Technology Conference on Monday, January 5th and Tuesday, January 6th in Las Vegas.
December 08, 2025 16:58 ET | Source: Nayax Ltd.

Nayax Announces Preliminary Results of Notes and Warrants Offering in Israel to Qualified Investors

HERZLIYA, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX) (the “Company”) announced today, further to its announcement of December 7, 2025, that the Company completed...
December 08, 2025 07:00 ET | Source: Kamada Ltd.

Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2026

Based on the Results of a Planned Interim Futility Analysis the Inhaled AAT Trial is Unlikely to Demonstrate a Statistically Significant Benefit in its Primary Endpoint Kamada Continues to Supply...
December 08, 2025 06:55 ET | Source: Ellomay Capital Ltd

Ellomay Capital Reports receipt of an Approval to Issue a Building Permit for the Dorad Power Plant Expansion

Tel-Aviv, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable...
December 07, 2025 09:30 ET | Source: Nayax Ltd.

Nayax Considering an Offering of Notes and Warrants in Israel

HERZLIYA, Israel, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX) (the “Company”), a global commerce payments and loyalty platform designed to help merchants scale their...
December 04, 2025 07:50 ET | Source: Foresight Autonomous Holdings Ltd.

Foresight: Eye-Net Receives $3 Million Investment Reflecting $55 Million Valuation

Ness Ziona, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, announced that...
December 04, 2025 07:30 ET | Source: Nayax Ltd.

Nayax Announces Acquisition of Lynkwell

HERZLIYA, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by...
December 04, 2025 07:00 ET | Source: Purple Biotech Ltd.

Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress

New data showcase the versatility and anti-tumor activity of the CAPTN-3 platform and its unique multi-arm design in treatment-resistant cancers REHOVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE)...